AI in Heart Failure: The Next Generation
This session explores the growing role of artificial intelligence (AI) in heart failure care and research. Faculty will highlight how AI-based tools can support diagnosis, identify stages of heart failure, and guide treatment decisions, including optimization of guideline-directed medical therapy (GDMT). Key trials such as COPILOT-HF and ASSIST-HF SIRIO will be discussed.
The session will also examine how AI is transforming heart failure research, including identifying eligible participants, adjudicating clinical events, and improving trial recruitment.
Learning Objectives
- Discuss the role of AI in diagnosing heart failure and identifying disease stages.
- Describe the role of AI in the treatment of heart failure, including optimization and uptitration of GDMT.
- Explore the potential of AI to expand heart failure research.